Balko et al., (2012) found that low DUSP4 expression was associated with basal-like breast cancer, high tumor proliferation after chemotherapy, and a decrease in the clinical chemotherapeutic response and achieved poorer pathologic complete remission rates and shorter recurrence-free survival periods than those in patients with high levels of DUSP4 expression. This evidence concerns the gene DUSP4 and breast carcinoma.